Altamira Therapeutics Ltd. (CYTO)
NASDAQ: CYTO · IEX Real-Time Price · USD
1.200
-0.140 (-10.45%)
At close: Jul 19, 2024, 4:00 PM
1.140
-0.060 (-5.00%)
Pre-market: Jul 22, 2024, 7:29 AM EDT
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $2.69 million as of July 22, 2024. Its market cap has decreased by -23.19% in one year.
Market Cap
2.69M
Enterprise Value
2.11M
1-Year Change
-23.19%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since December 31, 2014, Altamira Therapeutics's market cap has decreased from $113.10M to $2.69M, a decrease of -97.62%. That is a compound annual growth rate of -32.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.80M | 28.57% |
| Dec 29, 2023 | 1.40M | -65.85% |
| Dec 30, 2022 | 4.10M | -83.47% |
| Dec 31, 2021 | 24.80M | 86.47% |
| Dec 31, 2020 | 13.30M | 343.33% |
| Dec 31, 2019 | 3.00M | 36.36% |
| Dec 31, 2018 | 2.20M | -89.16% |
| Dec 29, 2017 | 20.30M | -44.69% |
| Dec 30, 2016 | 36.70M | -74.15% |
| Dec 31, 2015 | 142.00M | 25.55% |
| Dec 31, 2014 | 113.10M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INVO Bioscience | 2.85M |
| TC Biopharm (Holdings) | 2.82M |
| Virax Biolabs Group | 2.76M |
| Revelation Biosciences | 2.74M |
| ASLAN Pharmaceuticals | 2.69M |
| FOXO Technologies | 2.64M |
| Cingulate | 2.56M |
| Helius Medical Technologies | 2.52M |